75 related articles for article (PubMed ID: 3465965)
1. [Detection of anti-HTLV-III antibodies in hemophiliacs--prevalence rates in Japan and comparison of two assay systems].
Hattori T; Shojiro I; Uchida T; Matsuoka M; Yamamoto S; Hiyoshi Y; Fukutake K; Takatsuki K
Rinsho Ketsueki; 1986 Jul; 27(7):1057-63. PubMed ID: 3465965
[No Abstract] [Full Text] [Related]
2. Detection of antibodies to HTLV-I and -III in sera from Japanese hemophiliacs.
Abe T; Kinoshita T; Matsuda J; Ryu T; Ting RC; Aoki T; Robert-Guroff M; Miyakoshi H; Gallo RC
Cancer Res; 1985 Sep; 45(9 Suppl):4621s-4623s. PubMed ID: 2990696
[TBL] [Abstract][Full Text] [Related]
3. [Systematic detection of anti-LAV/HTLV-III antibodies in blood donors and hemophiliacs].
Muncunill J; Forteza A; Forner N; Forteza-Rei J
Med Clin (Barc); 1986 Apr; 86(13):565. PubMed ID: 3012224
[No Abstract] [Full Text] [Related]
4. Anti-HTLV-III and anti-HTLV-I antibodies and T cell subsets in hemophiliacs living in HTLV-I endemic and nonendemic areas of Japan.
Hattori T; Ikematsu S; Chosa T; Yamamoto S; Matsuoka M; Fukutake K; Robert-Guroff M; Takatsuki K
Acta Haematol; 1987; 77(1):25-9. PubMed ID: 2883800
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of antibodies to HTLV-III in AIDS risk groups in West Germany.
Erfle V; Hehlmann R; Mellert W; Krüger G; Seifried E; Heimpel H; Rasokat H; Lechler E; Holzer E; Hellstern P
Cancer Res; 1985 Sep; 45(9 Suppl):4627s-4629s. PubMed ID: 3860292
[TBL] [Abstract][Full Text] [Related]
6. [Anti-HTLV-III antibodies in hemophiliacs treated with concentrates of factors VIII or IX].
Aznar JA; Granda D; Jorquera J; González-Molina A; Carmona E; Peiró A; Gobernado M
Sangre (Barc); 1985; 30(5):934-5. PubMed ID: 3937254
[No Abstract] [Full Text] [Related]
7. [Penetration of anti-LVA/HTLV-III in type A and B hemophiliacs. Clinical and immunologic follow-up].
Ollero M; Leal M; Ramsey R; Wichman I; Vinuesa M; Muñoz J; Palmer E; Lissen E
Med Clin (Barc); 1986 Jan; 86(3):100-4. PubMed ID: 3485746
[No Abstract] [Full Text] [Related]
8. Detection of antibodies to human T-lymphotropic viruses type I and III in Japanese hemophiliacs.
Koyanagi Y; Kobayashi S; Harada S; Kikukawa R; Yamamoto N; Watanabe K; Okino F; Kajii T
AIDS Res; 1983-1984; 1(5):353-8. PubMed ID: 6100780
[TBL] [Abstract][Full Text] [Related]
9. [The HIV problem of factor VIII-substituted hemophiliacs from the diagnostic and prognostic viewpoints].
Wernet P; Göhring S; Sugg U; Brackmann HH; Kessler M; Egli H; Schneider W
Beitr Infusionther Klin Ernahr; 1987; 18():21-4. PubMed ID: 3125827
[No Abstract] [Full Text] [Related]
10. [Anti-HTLV-III/Lav antibodies, clinical symptoms and immunological determinations in hemophilia patients in Buenos Aires].
Anselmo A; Muchinik G; Pérez Bianco R; de la Barrera S; Riera NE; de Bracco MM; de Tezanos Pinto M
Medicina (B Aires); 1985; 45(3):312-3. PubMed ID: 3870213
[No Abstract] [Full Text] [Related]
11. [Anti-HTLV-III antibodies. Methods of detection and biological significance].
Ercilla MG; Barrera JM
Med Clin (Barc); 1986 Jan; 86(3):123-5. PubMed ID: 3457227
[No Abstract] [Full Text] [Related]
12. The prevalence of HTLV-III and HTLV-I antibodies in serum of hemophiliacs.
De Rossi A; Dalla Gassa O; Chieco Bianchi L; Dal Bo Zanon R; Boscaro M; Girolami A
Thromb Haemost; 1985 Dec; 54(4):897. PubMed ID: 3003957
[No Abstract] [Full Text] [Related]
13. [Preparation of monoclonal antibodies to HTLV-III and their application].
Sagawa K; Hattori T; Katagiri K; Morikawa T; Uchida T; Takatsuki K; Yokoyama M
Nihon Rinsho; 1986 Oct; 44(10):2169-76. PubMed ID: 3469442
[No Abstract] [Full Text] [Related]
14. [Anti-HTLV-I antibody and anti-HIV antibody in hemophiliacs, patients with renal disease and blood donors].
Kohno S; Masuyama Y; Dohtsu Y; Miyazaki T; Koga H; Yokoyama K; Taura K; Harada T; Yamaguchi K; Izumikawa K
Kansenshogaku Zasshi; 1987 May; 61(5):567-73. PubMed ID: 2822821
[No Abstract] [Full Text] [Related]
15. [Analysis of antibodies to human T-lymphotropic type III virus (anti-HTLV III) in a population at high risk for AIDS in Yugoslavia].
Burek V; Sakoman S; Hudolin V; Kovać D; Ficović P; Cepelja Z; Petricević I; Schönwald S; Soldo I; Borcić D
Lijec Vjesn; 1987 Jun; 109(6):216-9. PubMed ID: 3477674
[No Abstract] [Full Text] [Related]
16. [Sequential examination of anti-human immunodeficiency virus (HIV) antibodies by Western blot analysis and immunity in hemophiliacs].
Toyoda Y; Tonouchi T; Mimaya J; Takahashi S; Sugiyama T
Rinsho Ketsueki; 1988 Apr; 29(4):513-9. PubMed ID: 3043040
[No Abstract] [Full Text] [Related]
17. Association of HTLV-III antibodies and cellular immune status of hemophiliacs.
Tsoukas C; Gervais F; Shuster J; Gold P; O'Shaughnessy M; Robert-Guroff M
N Engl J Med; 1984 Dec; 311(23):1514-5. PubMed ID: 6095077
[No Abstract] [Full Text] [Related]
18. HTLV and immunosuppression.
Essex M; Kanki P; Allan J; Barin F; McLane MF; Lee TH; Kitchen L; Homma T; Malone G; Yokota T
Princess Takamatsu Symp; 1984; 15():309-18. PubMed ID: 6100649
[TBL] [Abstract][Full Text] [Related]
19. HTLV-III antibody status in household contacts of seropositive hemophiliacs.
Muntean W; Zenz W; Zaunschirm W; Teubl I; Heinz FX
Blood; 1986 Jun; 67(6):1780-1. PubMed ID: 3011153
[No Abstract] [Full Text] [Related]
20. Prevalence of HIV antibodies in hemophiliacs in Buenos Aires.
Muchinik GR; Anselmo AA; Picchio GR; Livellara B; Martín E; Bouzas MB; Pérez Bianco R; de Tezanos Pinto M
Medicina (B Aires); 1987; 47(4):367-70. PubMed ID: 3452726
[No Abstract] [Full Text] [Related]
[Next] [New Search]
